Potential reevaluation needed for the meta-analysis of high-pressure recruitment maneuvers in the 2023 ESICM guidelines on acute respiratory distress syndrome-Reference-Cited by-同舟云学术

Potential reevaluation needed for the meta-analysis of high-pressure recruitment maneuvers in the 2023 ESICM guidelines on acute respiratory distress syndrome

Published:2024-08-20 Issue: Volume: Page:
ISSN:0342-4642
Container-title:Intensive Care Medicine
language:en
Short-container-title:Intensive Care Med

Author:

Zeng Siyao,Li Yue,Yao Zhipeng,Zheng Junbo,Wang Hongliang^ORCID

Funder

the National Key Research and Development Program of China

Heilongjiang Provincial Postdoctoral Science Foundation

Heilongjiang Province Science Fund for Distinguished Young Scholars

Youth Medical Research Special Fund

Harbin Medical University Youth Fund

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00134-024-07601-6.pdf

Reference12 articles.

1. Grasselli G, Calfee CS, Camporota L, Poole D, Amato MBP, Antonelli M et al (2023) ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies. Intensive Care Med 49(7):727–759

2. Kacmarek RM, Villar J, Sulemanji D, Montiel R, Ferrando C, Blanco J et al (2016) Open lung approach for the acute respiratory distress syndrome: a pilot, randomized controlled trial. Crit Care Med 44(1):32–42

3. Lachmann B (1992) Open up the lung and keep the lung open. Intensive Care Med 18(6):319–321

4. Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G, et al (1998) Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 338(6):347–354

5. Constantin J-M, Jabaudon M, Lefrant J-Y, Jaber S, Quenot J-P, Langeron O, et al (2019) Personalised mechanical ventilation tailored to lung morphology versus low positive end-expiratory pressure for patients with acute respiratory distress syndrome in France (the LIVE study): a multicentre, single-blind, randomised controlled trial. Lan Respir Med 7(10):870–880